Reverse Remodeling in Pediatric Myocarditis With DCM Phenotype Impact of rASD and PAB

Thushiha Logeswaran1, Hakan Akintürk2, Dietmar Schranz3

  • 1Department of Pediatric Cardiology, Intensive Care Medicine and Congenital Heart Disease, Pediatric Heart Center, Justus-Liebig-University, Giessen, Germany.

JACC. Advances
|July 17, 2026
PubMed

Insights

A novel treatment strategy combining left atrial decompression and pulmonary artery banding (PAB) shows promise for myocardial recovery in young children with myocarditis-associated dilated cardiomyopathy (DCM). This approach may improve outcomes for pediatric heart failure patients.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Pediatric Critical Care

Background:

  • Myocarditis can progress to dilated cardiomyopathy (DCM) in children, leading to end-stage heart failure.
  • The immature myocardium has age-dependent regenerative capacity, suggesting potential for intervention.

Purpose of the Study:

  • To evaluate a staged, pathophysiology-guided strategy for myocardial recovery in infants and young children with myocarditis-associated DCM.
  • The strategy combines left atrial decompression and pulmonary artery banding (PAB).

Main Methods:

  • Retrospective analysis of 31 children under 3 years with biopsy-proven myocarditis and DCM phenotype.
  • Standardized multimodal assessment including echocardiography, cardiac MRI, hemodynamic assessment, and endomyocardial biopsy.
  • Interventions included creation of restrictive atrial communication and surgical PAB in selected patients.

Main Results:

  • Patients presented with severe heart dysfunction (ejection fraction 24% ± 6.2%, elevated filling pressures).
  • 90% overall survival at a median 2-year follow-up; 19% required heart transplantation.
  • Among patients selected for PAB, 76% achieved sustained functional recovery.

Conclusions:

  • A staged strategy of left atrial decompression and PAB can promote myocardial recovery in select pediatric patients with myocarditis-associated DCM.
  • This approach offers a potential therapeutic option for young children with severe heart dysfunction.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...